Sign in
4

Changes in Ownership

Niagen Bioscience, Inc. Filed Acc 0001415889-12-001898

Options or other derivatives

  • Director acquired 45,651 shares (grant or award)
  • Director returned 67,500 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Lockshin Curtis · Director

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-12-21 Returned to the company : show line 1 in the form Employee Stock Options (right to buy) −67,500 $1.54 2021-05-10 67,500 67,500 D
2012-12-21 Grant or award : show line 2 in the form Employee Stock Options (right to buy) +45,651 $0.95 2022-09-15 45,651 113,151 D
Loading xslF345X03/form4-12262012_071259.xml…